位置:首页 > 蛋白库 > DX39B_HUMAN
DX39B_HUMAN
ID   DX39B_HUMAN             Reviewed;         428 AA.
AC   Q13838; B0S8C0; O43496; Q0EFA1; Q2L6F9; Q53GL9; Q5RJ64; Q5RJ66; Q5ST94;
AC   Q5STB4; Q5STB5; Q5STB7; Q5STB8; Q5STU4; Q5STU5; Q5STU6; Q5STU8; Q71V76;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 216.
DE   RecName: Full=Spliceosome RNA helicase DDX39B {ECO:0000305};
DE            EC=3.6.4.13 {ECO:0000269|PubMed:17984224};
DE   AltName: Full=56 kDa U2AF65-associated protein;
DE   AltName: Full=ATP-dependent RNA helicase p47;
DE   AltName: Full=DEAD box protein UAP56;
DE   AltName: Full=HLA-B-associated transcript 1 protein;
GN   Name=DDX39B {ECO:0000312|HGNC:HGNC:13917}; Synonyms=BAT1, UAP56;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=7601445; DOI=10.1016/0888-7543(95)80203-x;
RA   Peelman L., Chardon P., Nunes M., Renard C., Geffrotin C., Vaiman M.,
RA   van Zeveren A., Coppieters W., van de Weghe A., Bouquet Y., Choy W.,
RA   Strominger J., Spies T.;
RT   "The BAT1 gene in the MHC encodes an evolutionarily conserved putative
RT   nuclear RNA helicase of the DEAD family.";
RL   Genomics 26:210-218(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney epithelium;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16702430; DOI=10.1534/genetics.106.057034;
RA   Shiina T., Ota M., Shimizu S., Katsuyama Y., Hashimoto N., Takasu M.,
RA   Anzai T., Kulski J.K., Kikkawa E., Naruse T., Kimura N., Yanagiya K.,
RA   Watanabe A., Hosomichi K., Kohara S., Iwamoto C., Umehara Y., Meyer A.,
RA   Wanner V., Sano K., Macquin C., Ikeo K., Tokunaga K., Gojobori T.,
RA   Inoko H., Bahram S.;
RT   "Rapid evolution of major histocompatibility complex class I genes in
RT   primates generates new disease alleles in humans via hitchhiking
RT   diversity.";
RL   Genetics 173:1555-1570(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 145-428.
RA   Allcock R.J.N., Price P., Gaudieri S., Leelayuwat C., Witt C.S.,
RA   Dawkins R.L.;
RT   "Homo sapiens BAT1 (BAT1) gene, partial cds; and PERB18 pseudogene,
RT   complete sequence.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, INTERACTION WITH U2AF2 AND THE SPLICEOSOME, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9242493; DOI=10.1101/gad.11.14.1864;
RA   Fleckner J., Zhang M., Valcarcel J., Green M.R.;
RT   "U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-
RT   branchpoint interaction.";
RL   Genes Dev. 11:1864-1872(1997).
RN   [10]
RP   FUNCTION, INTERACTION WITH ALYREF/THOC4 AND THE SPLICEOSOME, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11675789; DOI=10.1038/35098106;
RA   Luo M.-J., Zhou Z., Magni K., Christoforides C., Rappsilber J., Mann M.,
RA   Reed R.;
RT   "Pre-mRNA splicing and mRNA export linked by direct interactions between
RT   UAP56 and Aly.";
RL   Nature 413:644-647(2001).
RN   [11]
RP   INTERACTION WITH RBM8A; RNPS1; SRRM1 AND ALYREF/THOC4.
RX   PubMed=12944400; DOI=10.1074/jbc.m306856200;
RA   McCracken S., Longman D., Johnstone I.L., Caceres J.F., Blencowe B.J.;
RT   "An evolutionarily conserved role for SRm160 in 3'-end processing that
RT   functions independently of exon junction complex formation.";
RL   J. Biol. Chem. 278:44153-44160(2003).
RN   [12]
RP   HOMODIMERIZATION, AND INTERACTION WITH ALYREF/THOC4 AND DDX39A.
RX   PubMed=14667819; DOI=10.1016/s0888-7543(03)00235-0;
RA   Lehner B., Semple J.I., Brown S.E., Counsell D., Campbell R.D.,
RA   Sanderson C.M.;
RT   "Analysis of a high-throughput yeast two-hybrid system and its use to
RT   predict the function of intracellular proteins encoded within the human MHC
RT   class III region.";
RL   Genomics 83:153-167(2004).
RN   [13]
RP   IDENTIFICATION IN THE TREX COMPLEX, FUNCTION OF THE TREX COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15833825; DOI=10.1158/0008-5472.can-04-3624;
RA   Guo S., Hakimi M.A., Baillat D., Chen X., Farber M.J., Klein-Szanto A.J.,
RA   Cooch N.S., Godwin A.K., Shiekhattar R.;
RT   "Linking transcriptional elongation and messenger RNA export to metastatic
RT   breast cancers.";
RL   Cancer Res. 65:3011-3016(2005).
RN   [14]
RP   IDENTIFICATION IN THE TREX COMPLEX, FUNCTION OF THE TREX COMPLEX,
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH ALYREF/THOC4, AND
RP   DOMAIN.
RX   PubMed=15998806; DOI=10.1101/gad.1302205;
RA   Masuda S., Das R., Cheng H., Hurt E., Dorman N., Reed R.;
RT   "Recruitment of the human TREX complex to mRNA during splicing.";
RL   Genes Dev. 19:1512-1517(2005).
RN   [15]
RP   INTERACTION WITH THOC1, AND SUBCELLULAR LOCATION.
RX   PubMed=15870275; DOI=10.1128/mcb.25.10.4023-4033.2005;
RA   Li Y., Wang X., Zhang X., Goodrich D.W.;
RT   "Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically
RT   links RNA polymerase II and RNA processing factors.";
RL   Mol. Cell. Biol. 25:4023-4033(2005).
RN   [16]
RP   FUNCTION OF THE TREX COMPLEX.
RX   PubMed=17190602; DOI=10.1016/j.cell.2006.10.044;
RA   Cheng H., Dufu K., Lee C.-S., Hsu J.L., Dias A., Reed R.;
RT   "Human mRNA export machinery recruited to the 5' end of mRNA.";
RL   Cell 127:1389-1400(2006).
RN   [17]
RP   INTERACTION WITH HHV-5 PROTEIN UL69.
RX   PubMed=16478985; DOI=10.1128/mcb.26.5.1631-1643.2006;
RA   Lischka P., Toth Z., Thomas M., Mueller R., Stamminger T.;
RT   "The UL69 transactivator protein of human cytomegalovirus interacts with
RT   DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of
RT   unspliced RNA.";
RL   Mol. Cell. Biol. 26:1631-1643(2006).
RN   [18]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF 94-GLY--THR-96;
RP   LYS-95; GLU-197; ASP-199 AND 228-SER--THR-230.
RX   PubMed=17562711; DOI=10.1074/jbc.m702304200;
RA   Shen J., Zhang L., Zhao R.;
RT   "Biochemical characterization of the ATPase and helicase activity of UAP56,
RT   an essential pre-mRNA splicing and mRNA export factor.";
RL   J. Biol. Chem. 282:22544-22550(2007).
RN   [19]
RP   FUNCTION, INTERACTION WITH ALYREF, CATALYTIC ACTIVITY, AND MUTAGENESIS OF
RP   LYS-95.
RX   PubMed=17984224; DOI=10.1128/mcb.01341-07;
RA   Taniguchi I., Ohno M.;
RT   "ATP-dependent recruitment of export factor Aly/REF onto intronless mRNAs
RT   by RNA helicase UAP56.";
RL   Mol. Cell. Biol. 28:601-608(2008).
RN   [20]
RP   FUNCTION OF THE TREX COMPLEX (MICROBIAL INFECTION).
RX   PubMed=18974867; DOI=10.1371/journal.ppat.1000194;
RA   Boyne J.R., Colgan K.J., Whitehouse A.;
RT   "Recruitment of the complete hTREX complex is required for Kaposi's
RT   sarcoma-associated herpesvirus intronless mRNA nuclear export and virus
RT   replication.";
RL   PLoS Pathog. 4:E1000194-E1000194(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   INTERACTION WITH FYTTD1.
RX   PubMed=19836239; DOI=10.1016/j.cub.2009.09.041;
RA   Hautbergue G.M., Hung M.L., Walsh M.J., Snijders A.P., Chang C.T.,
RA   Jones R., Ponting C.P., Dickman M.J., Wilson S.A.;
RT   "UIF, a new mRNA export adaptor that works together with REF/ALY, requires
RT   FACT for recruitment to mRNA.";
RL   Curr. Biol. 19:1918-1924(2009).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-36, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH ALYREF AND SARNP.
RX   PubMed=20844015; DOI=10.1101/gad.1898610;
RA   Dufu K., Livingstone M.J., Seebacher J., Gygi S.P., Wilson S.A., Reed R.;
RT   "ATP is required for interactions between UAP56 and two conserved mRNA
RT   export proteins, Aly and CIP29, to assemble the TREX complex.";
RL   Genes Dev. 24:2043-2053(2010).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38 AND THR-172, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MX1.
RX   PubMed=21859714; DOI=10.1074/jbc.m111.251843;
RA   Wisskirchen C., Ludersdorfer T.H., Mueller D.A., Moritz E., Pavlovic J.;
RT   "Interferon-induced antiviral protein MxA interacts with the cellular RNA
RT   helicases UAP56 and URH49.";
RL   J. Biol. Chem. 286:34743-34751(2011).
RN   [29]
RP   FUNCTION.
RX   PubMed=22144908; DOI=10.1371/journal.pgen.1002386;
RA   Dominguez-Sanchez M.S., Barroso S., Gomez-Gonzalez B., Luna R.,
RA   Aguilera A.;
RT   "Genome instability and transcription elongation impairment in human cells
RT   depleted of THO/TREX.";
RL   PLoS Genet. 7:E1002386-E1002386(2011).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [31]
RP   INTERACTION WITH POLDIP3.
RX   PubMed=22928037; DOI=10.1371/journal.pone.0043804;
RA   Folco E.G., Lee C.S., Dufu K., Yamazaki T., Reed R.;
RT   "The proteins PDIP3 and ZC11A associate with the human TREX complex in an
RT   ATP-dependent manner and function in mRNA export.";
RL   PLoS ONE 7:E43804-E43804(2012).
RN   [32]
RP   FUNCTION, AND INTERACTION WITH CHTOP.
RX   PubMed=23299939; DOI=10.1038/emboj.2012.342;
RA   Chang C.T., Hautbergue G.M., Walsh M.J., Viphakone N., van Dijk T.B.,
RA   Philipsen S., Wilson S.A.;
RT   "Chtop is a component of the dynamic TREX mRNA export complex.";
RL   EMBO J. 32:473-486(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38; SER-41 AND THR-172, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   FUNCTION.
RX   PubMed=23222130; DOI=10.1093/nar/gks1188;
RA   Chi B., Wang Q., Wu G., Tan M., Wang L., Shi M., Chang X., Cheng H.;
RT   "Aly and THO are required for assembly of the human TREX complex and
RT   association of TREX components with the spliced mRNA.";
RL   Nucleic Acids Res. 41:1294-1306(2013).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-36, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [37]
RP   INTERACTION WITH LUZP4.
RX   PubMed=25662211; DOI=10.1093/nar/gkv070;
RA   Viphakone N., Cumberbatch M.G., Livingstone M.J., Heath P.R., Dickman M.J.,
RA   Catto J.W., Wilson S.A.;
RT   "Luzp4 defines a new mRNA export pathway in cancer cells.";
RL   Nucleic Acids Res. 43:2353-2366(2015).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-36, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 44-428 IN COMPLEX WITH ADP,
RP   FUNCTION, AND MUTAGENESIS OF CYS-198.
RX   PubMed=15585580; DOI=10.1073/pnas.0408172101;
RA   Shi H., Cordin O., Minder C.M., Linder P., Xu R.-M.;
RT   "Crystal structure of the human ATP-dependent splicing and export factor
RT   UAP56.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:17628-17633(2004).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 34-428, AND DIMERIZATION.
RX   PubMed=15296731; DOI=10.1016/j.str.2004.06.006;
RA   Zhao R., Shen J., Green M.R., MacMorris M., Blumenthal T.;
RT   "Crystal structure of UAP56, a DExD/H-box protein involved in pre-mRNA
RT   splicing and mRNA export.";
RL   Structure 12:1373-1381(2004).
CC   -!- FUNCTION: Involved in nuclear export of spliced and unspliced mRNA.
CC       Assembling component of the TREX complex which is thought to couple
CC       mRNA transcription, processing and nuclear export, and specifically
CC       associates with spliced mRNA and not with unspliced pre-mRNA. TREX is
CC       recruited to spliced mRNAs by a transcription-independent mechanism,
CC       binds to mRNA upstream of the exon-junction complex (EJC) and is
CC       recruited in a splicing- and cap-dependent manner to a region near the
CC       5' end of the mRNA where it functions in mRNA export to the cytoplasm
CC       via the TAP/NFX1 pathway. May undergo several rounds of ATP hydrolysis
CC       during assembly of TREX to drive subsequent loading of components such
CC       as ALYREF/THOC and CHTOP onto mRNA. Also associates with pre-mRNA
CC       independent of ALYREF/THOC4 and the THO complex. Involved in the
CC       nuclear export of intronless mRNA; the ATP-bound form is proposed to
CC       recruit export adapter ALYREF/THOC4 to intronless mRNA; its ATPase
CC       activity is cooperatively stimulated by RNA and ALYREF/THOC4 and ATP
CC       hydrolysis is thought to trigger the dissociation from RNA to allow the
CC       association of ALYREF/THOC4 and the NXF1-NXT1 heterodimer. Involved in
CC       transcription elongation and genome stability.
CC       {ECO:0000269|PubMed:11675789, ECO:0000269|PubMed:15585580,
CC       ECO:0000269|PubMed:15833825, ECO:0000269|PubMed:15998806,
CC       ECO:0000269|PubMed:17190602, ECO:0000269|PubMed:17562711,
CC       ECO:0000269|PubMed:17984224, ECO:0000269|PubMed:20844015,
CC       ECO:0000269|PubMed:22144908, ECO:0000269|PubMed:23222130,
CC       ECO:0000269|PubMed:23299939, ECO:0000269|PubMed:9242493}.
CC   -!- FUNCTION: Splice factor that is required for the first ATP-dependent
CC       step in spliceosome assembly and for the interaction of U2 snRNP with
CC       the branchpoint. Has both RNA-stimulated ATP binding/hydrolysis
CC       activity and ATP-dependent RNA unwinding activity. Even with the
CC       stimulation of RNA, the ATPase activity is weak. Can only hydrolyze ATP
CC       but not other NTPs. The RNA stimulation of ATPase activity does not
CC       have a strong preference for the sequence and length of the RNA.
CC       However, ssRNA stimulates the ATPase activity much more strongly than
CC       dsRNA. Can unwind 5' or 3' overhangs or blunt end RNA duplexes in
CC       vitro. The ATPase and helicase activities are not influenced by U2AF2;
CC       the effect of ALYREF/THOC4 is reported conflictingly with
CC       [PubMed:23299939] reporting a stimulatory effect.
CC       {ECO:0000269|PubMed:23299939, ECO:0000269|PubMed:9242493}.
CC   -!- FUNCTION: (Microbial infection) The TREX complex is essential for the
CC       export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless
CC       mRNAs and infectious virus production. {ECO:0000269|PubMed:18974867}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC         Evidence={ECO:0000269|PubMed:17984224};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.3 uM for ATP {ECO:0000269|PubMed:17562711};
CC         Vmax=0.126 uM/min/mg enzyme with ATP as substrate
CC         {ECO:0000269|PubMed:17562711};
CC   -!- SUBUNIT: Homodimer, and heterodimer with DDX39A (PubMed:11675789,
CC       PubMed:15833825, PubMed:14667819). Component of the
CC       transcription/export (TREX) complex at least composed of ALYREF/THOC4,
CC       DDX39B, SARNP/CIP29, CHTOP and the THO subcomplex; TREX seems to have
CC       dynamic structure involving ATP-dependent remodeling; in the complex
CC       bridges ALYREF/THOC4 and the THO complex, and, in a ATP-dependent
CC       manner, ALYREF/THOC4 and SARNP/CIP29 (PubMed:11675789, PubMed:15833825,
CC       PubMed:14667819, PubMed:15998806, PubMed:17984224, PubMed:20844015,
CC       PubMed:23299939). Component of the spliceosome. Interacts directly with
CC       U2AF2 (PubMed:9242493). Interacts with RBM8A, RNPS1 and SRRM1,
CC       FYTTD1/UIF, THOC1, MX1 and POLDIP3 (PubMed:12944400, PubMed:15870275,
CC       PubMed:19836239, PubMed:21859714, PubMed:22928037). Interacts with
CC       LUZP4 (PubMed:25662211). {ECO:0000269|PubMed:11675789,
CC       ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:14667819,
CC       ECO:0000269|PubMed:15833825, ECO:0000269|PubMed:15870275,
CC       ECO:0000269|PubMed:15998806, ECO:0000269|PubMed:17984224,
CC       ECO:0000269|PubMed:19836239, ECO:0000269|PubMed:20844015,
CC       ECO:0000269|PubMed:21859714, ECO:0000269|PubMed:22928037,
CC       ECO:0000269|PubMed:23299939, ECO:0000269|PubMed:25662211,
CC       ECO:0000269|PubMed:9242493}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human
CC       cytomegalovirus/HHV-5 protein UL69. {ECO:0000269|PubMed:16478985}.
CC   -!- INTERACTION:
CC       Q13838; Q86V81: ALYREF; NbExp=4; IntAct=EBI-348622, EBI-347640;
CC       Q13838; Q9Y3Y2: CHTOP; NbExp=7; IntAct=EBI-348622, EBI-347794;
CC       Q13838; Q9Y3Y2-3: CHTOP; NbExp=5; IntAct=EBI-348622, EBI-11984237;
CC       Q13838; O00148: DDX39A; NbExp=4; IntAct=EBI-348622, EBI-348253;
CC       Q13838; Q13838: DDX39B; NbExp=4; IntAct=EBI-348622, EBI-348622;
CC       Q13838; Q96QD9: FYTTD1; NbExp=3; IntAct=EBI-348622, EBI-724553;
CC       Q13838; Q9P127: LUZP4; NbExp=3; IntAct=EBI-348622, EBI-10198848;
CC       Q13838; P78317: RNF4; NbExp=3; IntAct=EBI-348622, EBI-2340927;
CC       Q13838; P82979: SARNP; NbExp=4; IntAct=EBI-348622, EBI-347495;
CC       Q13838; O00560: SDCBP; NbExp=3; IntAct=EBI-348622, EBI-727004;
CC       Q13838; P09012: SNRPA; NbExp=3; IntAct=EBI-348622, EBI-607085;
CC       Q13838; P26368-2: U2AF2; NbExp=3; IntAct=EBI-348622, EBI-11097439;
CC       Q13838; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-348622, EBI-10180829;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus speckle. Cytoplasm. Note=Can
CC       translocate to the cytoplasm in the presence of MX1. TREX complex
CC       assembly seems to occur in regions surrounding nuclear speckles known
CC       as perispeckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13838-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13838-2; Sequence=VSP_026347;
CC   -!- DOMAIN: The helicase C-terminal domain mediates interaction with
CC       ALYREF/THOC4. {ECO:0000269|PubMed:15998806}.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DECD subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z37166; CAA85523.1; -; mRNA.
DR   EMBL; BT009909; AAP88911.1; -; mRNA.
DR   EMBL; AK222912; BAD96632.1; -; mRNA.
DR   EMBL; AB088115; BAC54953.1; -; Genomic_DNA.
DR   EMBL; AB103621; BAF31287.1; -; Genomic_DNA.
DR   EMBL; AB202112; BAE78637.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63306.1; -; Genomic_DNA.
DR   EMBL; AL662801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX001040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX248516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927320; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR753820; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR753864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03404.1; -; Genomic_DNA.
DR   EMBL; BC000361; AAH00361.1; -; mRNA.
DR   EMBL; BC013006; AAH13006.1; -; mRNA.
DR   EMBL; AF029061; AAB94615.1; -; Genomic_DNA.
DR   EMBL; AF029062; AAC63046.1; -; Genomic_DNA.
DR   CCDS; CCDS4697.1; -. [Q13838-1]
DR   PIR; I37201; I37201.
DR   RefSeq; NP_004631.1; NM_004640.6. [Q13838-1]
DR   RefSeq; NP_542165.1; NM_080598.5. [Q13838-1]
DR   PDB; 1T5I; X-ray; 1.90 A; A=259-428.
DR   PDB; 1T6N; X-ray; 1.94 A; A/B=34-251.
DR   PDB; 1XTI; X-ray; 1.95 A; A=46-428.
DR   PDB; 1XTJ; X-ray; 2.70 A; A=44-423.
DR   PDB; 1XTK; X-ray; 2.40 A; A=45-428.
DR   PDB; 7APK; EM; 3.30 A; H/P/h/p=1-428.
DR   PDBsum; 1T5I; -.
DR   PDBsum; 1T6N; -.
DR   PDBsum; 1XTI; -.
DR   PDBsum; 1XTJ; -.
DR   PDBsum; 1XTK; -.
DR   PDBsum; 7APK; -.
DR   AlphaFoldDB; Q13838; -.
DR   SMR; Q13838; -.
DR   BioGRID; 113649; 397.
DR   CORUM; Q13838; -.
DR   IntAct; Q13838; 79.
DR   MINT; Q13838; -.
DR   STRING; 9606.ENSP00000379475; -.
DR   DrugBank; DB11638; Artenimol.
DR   TCDB; 3.A.18.1.1; the nuclear mrna exporter (mrna-e) family.
DR   GlyGen; Q13838; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13838; -.
DR   MetOSite; Q13838; -.
DR   PhosphoSitePlus; Q13838; -.
DR   SwissPalm; Q13838; -.
DR   BioMuta; DDX39B; -.
DR   DMDM; 2500529; -.
DR   EPD; Q13838; -.
DR   jPOST; Q13838; -.
DR   MassIVE; Q13838; -.
DR   MaxQB; Q13838; -.
DR   PaxDb; Q13838; -.
DR   PeptideAtlas; Q13838; -.
DR   PRIDE; Q13838; -.
DR   ProteomicsDB; 59701; -. [Q13838-1]
DR   ProteomicsDB; 59702; -. [Q13838-2]
DR   Antibodypedia; 27068; 364 antibodies from 28 providers.
DR   DNASU; 7919; -.
DR   Ensembl; ENST00000383508.6; ENSP00000373000.2; ENSG00000215425.11. [Q13838-1]
DR   Ensembl; ENST00000396172.6; ENSP00000379475.1; ENSG00000198563.14. [Q13838-1]
DR   Ensembl; ENST00000400295.5; ENSP00000383151.1; ENSG00000215425.11. [Q13838-1]
DR   Ensembl; ENST00000400296.5; ENSP00000383152.1; ENSG00000215425.11. [Q13838-1]
DR   Ensembl; ENST00000412106.5; ENSP00000393712.1; ENSG00000225073.10. [Q13838-1]
DR   Ensembl; ENST00000412330.5; ENSP00000398775.1; ENSG00000225859.10. [Q13838-1]
DR   Ensembl; ENST00000413678.5; ENSP00000391463.1; ENSG00000229496.10. [Q13838-1]
DR   Ensembl; ENST00000414440.5; ENSP00000411853.1; ENSG00000229496.10. [Q13838-1]
DR   Ensembl; ENST00000415689.5; ENSP00000390999.1; ENSG00000225073.10. [Q13838-1]
DR   Ensembl; ENST00000416863.5; ENSP00000407419.1; ENSG00000229496.10. [Q13838-1]
DR   Ensembl; ENST00000430784.5; ENSP00000399030.1; ENSG00000235439.10. [Q13838-1]
DR   Ensembl; ENST00000431360.5; ENSP00000404695.1; ENSG00000235439.10. [Q13838-1]
DR   Ensembl; ENST00000441425.5; ENSP00000388880.1; ENSG00000230624.10. [Q13838-1]
DR   Ensembl; ENST00000445218.5; ENSP00000411136.1; ENSG00000225859.10. [Q13838-1]
DR   Ensembl; ENST00000448296.5; ENSP00000405560.1; ENSG00000225859.10. [Q13838-1]
DR   Ensembl; ENST00000453138.5; ENSP00000387994.1; ENSG00000230624.10. [Q13838-1]
DR   Ensembl; ENST00000456476.5; ENSP00000400326.1; ENSG00000225073.10. [Q13838-1]
DR   Ensembl; ENST00000456666.5; ENSP00000394160.1; ENSG00000230624.10. [Q13838-1]
DR   Ensembl; ENST00000458640.5; ENSP00000416269.1; ENSG00000198563.14. [Q13838-1]
DR   GeneID; 7919; -.
DR   KEGG; hsa:7919; -.
DR   MANE-Select; ENST00000396172.6; ENSP00000379475.1; NM_004640.7; NP_004631.1.
DR   UCSC; uc003ntt.4; human. [Q13838-1]
DR   CTD; 7919; -.
DR   DisGeNET; 7919; -.
DR   GeneCards; DDX39B; -.
DR   HGNC; HGNC:13917; DDX39B.
DR   HPA; ENSG00000198563; Low tissue specificity.
DR   MIM; 142560; gene.
DR   neXtProt; NX_Q13838; -.
DR   OpenTargets; ENSG00000198563; -.
DR   PharmGKB; PA25262; -.
DR   VEuPathDB; HostDB:ENSG00000198563; -.
DR   eggNOG; KOG0329; Eukaryota.
DR   GeneTree; ENSGT00940000160110; -.
DR   HOGENOM; CLU_003041_1_0_1; -.
DR   InParanoid; Q13838; -.
DR   OMA; IKPICRK; -.
DR   PhylomeDB; Q13838; -.
DR   TreeFam; TF300442; -.
DR   PathwayCommons; Q13838; -.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-73856; RNA Polymerase II Transcription Termination.
DR   Reactome; R-HSA-9013418; RHOBTB2 GTPase cycle.
DR   SABIO-RK; Q13838; -.
DR   SignaLink; Q13838; -.
DR   SIGNOR; Q13838; -.
DR   BioGRID-ORCS; 7919; 440 hits in 1090 CRISPR screens.
DR   EvolutionaryTrace; Q13838; -.
DR   GeneWiki; BAT1; -.
DR   GenomeRNAi; 7919; -.
DR   Pharos; Q13838; Tbio.
DR   PRO; PR:Q13838; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q13838; protein.
DR   Bgee; ENSG00000198563; Expressed in granulocyte and 177 other tissues.
DR   ExpressionAtlas; Q13838; baseline and differential.
DR   Genevisible; Q13838; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; IDA:BHF-UCL.
DR   GO; GO:0000346; C:transcription export complex; IDA:UniProtKB.
DR   GO; GO:0005687; C:U4 snRNP; IDA:BHF-UCL.
DR   GO; GO:0005688; C:U6 snRNP; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; EXP:Reactome.
DR   GO; GO:0008186; F:ATP-dependent activity, acting on RNA; IDA:UniProtKB.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; IDA:UniProtKB.
DR   GO; GO:0030621; F:U4 snRNA binding; IDA:BHF-UCL.
DR   GO; GO:0017070; F:U6 snRNA binding; IDA:BHF-UCL.
DR   GO; GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IGI:UniProtKB.
DR   GO; GO:2000002; P:negative regulation of DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IMP:UniProtKB.
DR   GO; GO:0006405; P:RNA export from nucleus; TAS:Reactome.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IDA:BHF-UCL.
DR   GO; GO:0008380; P:RNA splicing; IDA:BHF-UCL.
DR   GO; GO:0000245; P:spliceosomal complex assembly; IDA:BHF-UCL.
DR   GO; GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB.
DR   DisProt; DP02724; -.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Helicase; Hydrolase; Isopeptide bond; mRNA processing; mRNA splicing;
KW   mRNA transport; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding; Spliceosome; Transport; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   CHAIN           2..428
FT                   /note="Spliceosome RNA helicase DDX39B"
FT                   /id="PRO_0000055071"
FT   DOMAIN          76..249
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          261..422
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           45..73
FT                   /note="Q motif"
FT   MOTIF           196..199
FT                   /note="DECD box"
FT   COMPBIAS        1..22
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         89..96
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   MOD_RES         36
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         41
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         172
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   CROSSLNK        36
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         114
FT                   /note="V -> VYLGRVLGRGFWLGLV (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_026347"
FT   MUTAGEN         94..96
FT                   /note="GKT->AAA: Loss of ATPase and helicase activity."
FT                   /evidence="ECO:0000269|PubMed:17562711"
FT   MUTAGEN         95
FT                   /note="K->A: Loss of ATPase and helicase activity."
FT                   /evidence="ECO:0000269|PubMed:17562711,
FT                   ECO:0000269|PubMed:17984224"
FT   MUTAGEN         197
FT                   /note="E->A: Loss of ATPase and helicase activity."
FT                   /evidence="ECO:0000269|PubMed:17562711"
FT   MUTAGEN         198
FT                   /note="C->A: No effect on ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:15585580"
FT   MUTAGEN         199
FT                   /note="D->A: Increased ATPase activity and loss of helicase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:17562711"
FT   MUTAGEN         228..230
FT                   /note="SAT->AAA: Decreased ATPase activity and loss of
FT                   helicase activity."
FT                   /evidence="ECO:0000269|PubMed:17562711"
FT   CONFLICT        289
FT                   /note="Q -> R (in Ref. 3; BAD96632)"
FT                   /evidence="ECO:0000305"
FT   HELIX           47..50
FT                   /evidence="ECO:0007829|PDB:1XTI"
FT   HELIX           54..62
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           70..80
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          85..88
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           95..106
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          116..119
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           123..136
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   TURN            137..139
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          145..149
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           154..163
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          167..171
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           173..181
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:1XTJ"
FT   STRAND          192..197
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           198..202
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           205..216
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          220..229
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   TURN            233..235
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   HELIX           236..240
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          247..250
FT                   /evidence="ECO:0007829|PDB:1T6N"
FT   STRAND          263..268
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           271..273
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           274..284
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          288..293
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           297..309
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          314..317
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          319..321
FT                   /evidence="ECO:0007829|PDB:1XTK"
FT   HELIX           323..334
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          335..337
FT                   /evidence="ECO:0007829|PDB:1XTJ"
FT   STRAND          339..345
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           353..355
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          357..363
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           368..378
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           380..382
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          386..391
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   HELIX           394..407
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          411..413
FT                   /evidence="ECO:0007829|PDB:1T5I"
FT   STRAND          417..419
FT                   /evidence="ECO:0007829|PDB:1XTJ"
FT   HELIX           420..422
FT                   /evidence="ECO:0007829|PDB:1XTI"
SQ   SEQUENCE   428 AA;  48991 MW;  7A55167BF576FB6F CRC64;
     MAENDVDNEL LDYEDDEVET AAGGDGAEAP AKKDVKGSYV SIHSSGFRDF LLKPELLRAI
     VDCGFEHPSE VQHECIPQAI LGMDVLCQAK SGMGKTAVFV LATLQQLEPV TGQVSVLVMC
     HTRELAFQIS KEYERFSKYM PNVKVAVFFG GLSIKKDEEV LKKNCPHIVV GTPGRILALA
     RNKSLNLKHI KHFILDECDK MLEQLDMRRD VQEIFRMTPH EKQVMMFSAT LSKEIRPVCR
     KFMQDPMEIF VDDETKLTLH GLQQYYVKLK DNEKNRKLFD LLDVLEFNQV VIFVKSVQRC
     IALAQLLVEQ NFPAIAIHRG MPQEERLSRY QQFKDFQRRI LVATNLFGRG MDIERVNIAF
     NYDMPEDSDT YLHRVARAGR FGTKGLAITF VSDENDAKIL NDVQDRFEVN ISELPDEIDI
     SSYIEQTR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025